Bright Minds Biosciences
(NASDAQ) DRUG
Bright Minds Biosciences Financials at a Glance
Market Cap
$699.39M
Revenue (TTM)
$0.00
Net Income (TTM)
$19.84M
EPS (TTM)
$-1.94
P/E Ratio
-36.84
Dividend
$0.00
Beta (Volatility)
1.04 (Average)
Dividend
$0.00
Beta (Volatility)
1.04 (Average)
Price
$71.89
Volume
4,677
Open
$70.39
Price
$71.89
Volume
4,677
Open
$70.39
Previous Close
$71.89
Daily Range
$68.77 - $73.02
52-Week Range
$23.18 - $123.75
Dividend
$0.00
Beta (Volatility)
1.04 (Average)
Price
$71.89
Volume
4,677
Open
$70.39
Previous Close
$71.89
Daily Range
$68.77 - $73.02
52-Week Range
$23.18 - $123.75
DRUG News
DRUG: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Bright Minds Biosciences
Industry
Biotechnology
Sector
Health CareEmployees
0
CEO
Ian B. McDonald
Website
www.brightmindsbio.comHeadquarters
New York City, BC V6E 4N7, CA
DRUG Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-27%
Return on Capital
-22%
Return on Assets
-22%
Earnings Yield
-2.71%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$699.39M
Shares Outstanding
9.79M
Volume
4.68K
Short Interest
0.00%
Avg. Volume
168.69K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$13.94M
EBITDA
$13.86M
Operating Cash Flow
$8.69M
Capital Expenditure
$0.00
Free Cash Flow
$8.69M
Cash & ST Invst.
$82.91M
Total Debt
$125.78K
Bright Minds Biosciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$699.39M
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$7.57M
-15349.6%
EBITDA
$6.88M
-329.4%
Quarterly Fundamentals
Net Cash
$88.94M
+54.1%
Accounts Receivable
$502.68K
+650.0%
Inventory
$0.00
N/A
Long Term Debt
$16.74K
-84.8%
Short Term Debt
$88.16K
+21.3%
Return on Assets
-21.84%
N/A
Return on Invested Capital
-21.52%
N/A
Free Cash Flow
$5.82M
-289.2%
Operating Cash Flow
$5.82M
-289.2%